ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Supernus Sues Apotex for Infringement of Oxtellar XR? Patents americanpharmaceuticalreview
July 07, 2020Supernus Pharmaceuticals announced it has sued generic drug maker Apotex Inc. and Apotex Corp. for infringement of nine patents covering its antiepileptic drug Oxtellar XR?. -
Pharma industry witnesses 50 deals worth $3 billion in April 2020 expresspharma
May 08, 2020Three major deals contributed 72 per cent of deal value in April 2020. -
Cadila Healthcare in pact with Supernus Pharmaceuticals
expressbpd
March 10, 2017Under the terms of the pact, Supernus grants a license to market Zydus generic version of Trokendi XR (topiramate) extended-release capsules beginning on January 1, 2023
Pharma Sources Insight January 2025
